PND35 Modeling The Economic Impact Of Incorporating AbobotulinumtoxinA Into An Institutional Formulary For FDA-Approved Indications
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.819
https://www.valueinhealthjournal.com/article/S1098-3015(21)01036-6/fulltext
Title :
PND35 Modeling The Economic Impact Of Incorporating AbobotulinumtoxinA Into An Institutional Formulary For FDA-Approved Indications
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01036-6&doi=10.1016/j.jval.2021.04.819
First page :
Section Title :
Open access? :
No
Section Order :
10325